Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis

  • Labrinus van Manen (Contributor)
  • Jesse V. Groen (Creator)
  • Hein Putter (Creator)
  • Alexander L. Vahrmeijer (Creator)
  • Rutger-Jan Swijnenburg (Contributor)
  • Bert A. Bonsing (Creator)
  • J. Sven D. Mieog (Contributor)

Dataset

Description

Purpose: It is suggested that tumour markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) could be used to predict the stage of pancreatic cancer. However, optimal cut-off values for CEA and CA19-9 are disputable. This study aim...
Date made available2020
PublisherTaylor & Francis

Access Dataset

Cite this